| Board of
Directors |
Chairman:Said Darwazeh
General Manager: Mr. Mazen Darwazah
General Manager of Pharmaceuticals : Mr. Garbial Kalisse |
| Paid
Capital
|
$ 24,000,000 US
|
| Personnel |
550 employees |
| Company
Classification |
Private shareholding
|
|
Certification |
Hikma is the first Arab drug
manufacturing company to successfully pass FDA inspection and obtain FDA
approval for some of its products. Hikma has been certified under the ISO
9001 quality management system. Hikma is also the first Arab company to
obtain British MCA (Medicines Control Agency) approval to register and
export one of its products to the UK. |
| Markets |
Over thirty countries in North
Africa, the Middle East and Eastern Europe, USA, Portugal and the Far East.
|
| Therapeutic Categories |
Analgesics and anti-rheumatics, anabolic steroids, antidiabetics,
antihistamines, anti-infectives ( injectables and orals), antispasmodics,
antiulcers and antacids, cardiovasculars, corticosteroids, cough and cold
preparations, hormone analogs, minerals and nutritional additives,
psychotropic drugs, & immunosuppressants.
|
| Licenses |
Fujisawa, Dainippon, Chugai and others |
| Address |
P.O. Box 182400, Amman, 11118
Jordan |
| Telephone |
++ 962-6-582 4222,
++ 962-6-5802900
|
| Fax |
++ 962-6-5817102 |
| Telex |
22328
Hikma Jo |
| E-mail |
mrkt@hikma.com |
| Web Site |
www.hikma.com
|
|